# Bio-availability of Rectal Artesunate in Children With Severe Falciparum Malaria

> **NCT02492178** · PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 82 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Intrarectal artesunate
- **DRUG:** Intravenous artesunate
- **DRUG:** Intravenous quinine

## Key facts

- **NCT ID:** NCT02492178
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2015-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02492178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02492178, "Bio-availability of Rectal Artesunate in Children With Severe Falciparum Malaria". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02492178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*